Potent and subtype-selective (>1000-fold) PPARgamma agonist [1]. Angiogenesis inhibitor [3]. Apoptosis inhibitor [4]. Anti-inflammatory [4]. Anti-hyperglycemic and anti-hyperlipidemic agent [1]. Antidiabetic. The glucose-lowering effect in rats is 100-fold more potent than that of troglitazone [2].
Buffer:
Solid
CAS Number:
[196808-24-9]
* VAT and and shipping costs not included. Errors and price changes excepted